SCHEDULE 13G/A: Ameriprise Financial and Columbia Management Reduce Stake in GoodRx Holdings Below 5%

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have reported reducing their beneficial ownership in GoodRx Holdings, Inc. Class A Common Stock to 4.3% as of March 31, 2025.

Summary

• Ameriprise Financial, Inc. and Columbia Management Investment Advisers, LLC filed an Amendment No. 2 to Schedule 13G for GoodRx Holdings, Inc.
• The filing reports their beneficial ownership of GoodRx Holdings, Inc. Class A Common Stock as of March 31, 2025.
• Ameriprise Financial, Inc. and Columbia Management Investment Advisers, LLC collectively beneficially own 4,634,771 shares and 4,632,130 shares, respectively, representing 4.3% of the Class A Common Stock.
• This percentage is below the 5% threshold, indicating a reduction in their previously reported stake.
• Ameriprise Financial, Inc. is the parent holding company of Columbia Management Investment Advisers, LLC.

Sentiment

Score: 4

Explanation: The filing reports a reduction in institutional ownership below a key threshold, which is generally viewed as a slightly negative signal by the market, indicating a potential decrease in investor confidence or a strategic divestment by a major holder.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may perceive a reduction in institutional ownership as a negative signal, potentially impacting investor sentiment and stock price.
• The filing itself does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

GoodRx Holdings Inc., GRX, Ameriprise Financial Inc., Columbia Management Investment Advisers LLC, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Ownership, Investment Management, SEC Filing